Zymeworks (Zyme) 2026 Earnings: An Investor Guidebook
As Zymeworks gears up for 2026 earnings, investors should focus on cash runway, pipeline milestones, and collaboratio...
Innovative Skincare Clinical presents study results and product evaluations to help you assess effectiveness and safety in modern skincare.
1,162 articlesAs Zymeworks gears up for 2026 earnings, investors should focus on cash runway, pipeline milestones, and collaboratio...
A clear guide to reading RMTI's Q1 2026 earnings call, what the numbers mean, and how to spot the catalysts that can ...
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
A wave of healthcare AI players trading under $50 is drawing attention for real progress in partnerships and revenue....
Investing in early-stage biotech requires a steady playbook. This article breaks down Lantern Pharma (LTRN) in 2025, ...
Mind tech (mind) 2027 is shaping a new era for investors who seek durable growth in neurotech and digital mental heal...
When a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
A breakthrough blood test that screens for 50+ cancers is edging toward real-world use. This article breaks down what...
As biotech investors digest Recursion's latest quarterly results, this Deep Dive breaks down what recursion (rxrx) 20...
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Capricor's small-cap biotech story hinges on milestones, cash runway, and clinical progress. This guide breaks down w...
A wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...